文献速递心胸血管麻醉

个体化流量控制通气与压力控制通气在心脏手术中的随机对照试验

Individualized Flow-controlled versus Pressure-controlled Ventilation in Cardiac Surgery: A Randomized Controlled Trial.
PubMed 文献 · Anesthesiology · 2025-11-17

该单中心随机对照试验纳入140例体外循环心脏手术成人患者,1:1分配至个体化流量控制通气(FCV)或压力控制通气(PCV)组。主要终点为体外循环后6小时血浆IL-8水平,结果两组无显著差异;但FCV组机械功率降低55%,且探索性次要结局显示肺部并发症和肺外并发症发生率更低、住院时间更短。

要点

  • FCV未降低体外循环后6小时血浆IL-8水平。
  • FCV组围术期机械功率较PCV组降低55%。
  • 探索性分析提示FCV组术后并发症更少、住院更短。

核心结论

  • 在体外循环心脏手术患者中,个体化FCV与PCV相比未显著降低术后6小时血浆IL-8水平。
  • FCV应用使围术期机械功率降低55%,且探索性次要结局支持未来进一步研究。

研究设计与样本

  • 单中心随机对照试验,纳入140例体外循环心脏手术成人患者,1:1分配至FCV或PCV组。
  • FCV组采用顺应性引导的PEEP和驱动压,PCV组采用顺应性引导的PEEP和驱动压,潮气量6-8 ml/kg预测体重。
  • 主要终点为体外循环后6小时血浆IL-8水平;探索性次要结局包括术后肺部及肺外并发症发生率和住院时间。

主要发现

  • FCV组与PCV组术后IL-8中位数无显著差异(FCV 3.08 vs PCV 3.60;β=0.08 pg/ml;95%CI -0.17至0.33;P=0.573)。
  • FCV组驱动压和潮气量更高,但呼吸频率和分钟通气量更低,机械功率降低55%。
  • FCV组术后单项肺部并发症(如确诊肺炎、中重度低氧血症)及任何肺外并发症发生率更低,住院时间更短。

关键数值与推荐

  • 主要终点:体外循环后6小时血浆IL-8水平,FCV组中位数3.08,PCV组3.60,β=0.08 pg/ml,95%CI -0.17至0.33,P=0.573。
  • FCV组围术期机械功率较PCV组降低55%。
  • 潮气量设定为6-8 ml/kg预测体重,PEEP和驱动压均基于顺应性引导。

临床怎么用

  • 对于体外循环心脏手术患者,个体化FCV可显著降低机械功率,可能减少术后肺部及肺外并发症并缩短住院时间。
  • FCV未显著改变术后IL-8水平,其临床获益需进一步研究证实。

局限性

  • 单中心研究,样本量140例,探索性次要结局需谨慎解读。
  • 主要终点为替代指标IL-8,未能直接反映临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing on-pump cardiac surgery are at high risk for perioperative lung injury and a hyperinflammatory state associated with postoperative complications. The authors investigated the hypothesis that flow-controlled ventilation (FCV) reduces the inflammatory stimulus compared to conventional pressure-controlled ventilation (PCV) in this patient cohort. FCV has the unique feature of controlling airway flows during inspiration and expiration and the potential to reduce mechanical power of invasive ventilation. METHODS: In this single-center randomized controlled trial, 140 adult patients undergoing cardiac surgery with cardiopulmonary bypass were allocated 1:1 to FCV or PCV from August 10, 2020, to November 16, 2022. Participants received perioperatively either individualized FCV with a compliance-guided positive end-expiratory pressure (PEEP) and a compliance-guided driving pressure (ΔP) or PCV with a compliance-guided PEEP and ΔP for tidal volumes of 6 to 8 ml/kg predicted body weight. Postoperative plasmatic interleukin 8 (IL-8) levels 6 h after cardiopulmonary bypass were defined as the primary endpoint. Explorative secondary outcomes included incidences of postoperative pulmonary and extrapulmonary complications and hospital length of stay. RESULTS: Median postoperative IL-8 levels did not differ significantly between FCV and PCV (FCV, 3.08 vs . PCV, 3.60; β, 0.08 pg/ml; 95% CI, -0.17 to 0.33; P = 0.573). ΔP values and tidal volumes were higher in the FCV group but FCV yielded lower respiratory rates and minute volumes required for normocapnia. As a result, the FCV approach reduced the perioperatively applied mechanical power by 55%. After FCV, incidences of single postoperative pulmonary complications ( e.g. , confirmed pneumonia, moderate and severe hypoxemia) and any postoperative extrapulmonary complication were lower and the hospital stay shorter. CONCLUSIONS: FCV did not reduce plasmatic IL-8 levels at the predefined timepoint 6 h after cardiopulmonary bypass. However, the reduction of mechanical power during individualized FCV application and the findings of the explorative secondary study outcomes justify future trials.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Becker S, Kurz CT, Schnitzler R, et al. Individualized Flow-controlled versus Pressure-controlled Ventilation in Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. 2025. PMID: 41247873. doi:10.1097/ALN.0000000000005851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。